ARTICLE | Company News
ValiRx, Cancer Research UK deal
July 14, 2008 7:00 AM UTC
Cancer Research Technology Ltd., the technology transfer arm of Cancer Research UK, granted ValiRx a12-month option to in-license exclusive, worldwide rights to VAL201 to treat cancer. The Src kinas...